• Mon, September 16, 2024
Reni Benjamin Reiterated (STRO) at Buy and Held Target at $17 on, Sep 16th, 2024
Reni Benjamin of JMP Securities, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $17 on, Sep 16th, 2024.
Reni has made no other calls on STRO in the last 4 months.
There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Reni's Rating of Hold.
This is the rating of the analyst that currently disagrees with Reni
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $15 on, Friday, August 16th, 2024